BRIEF published on 07/23/2025 at 09:29, 5 months 23 days ago Vara Research publie ses estimations pour le deuxième trimestre 2025 de Shell plc Perspectives Financières Recherche Vara Actualités EQS T2 2025 Estimations De Shell
BRIEF published on 07/23/2025 at 09:10, 5 months 23 days ago BioNxt Advances Cladribine Thin-Film Development Multiple Sclerosis Cladribine Drug Delivery BioNxt Solutions Sublingual Thin-Film
BRIEF published on 07/23/2025 at 09:10, 5 months 23 days ago BioNxt fait progresser le développement de couches minces de cladribine Sclérose En Plaques Cladribine Solutions BioNxt Administration De Médicaments Film Mince Sublingual
BRIEF published on 07/23/2025 at 09:05, 5 months 23 days ago Transition Evergreen : Nouveau report de publication des comptes annuels 2024 Liquidation Judiciaire Transition Evergreen Comptes Annuels 2024 Conciliation Créanciers Société Holding
BRIEF published on 07/23/2025 at 09:05, 5 months 23 days ago Evergreen Transition: New postponement of publication of 2024 annual accounts Judicial Liquidation Holding Company Evergreen Transition Annual Accounts 2024 Creditor Conciliation
BRIEF published on 07/23/2025 at 09:03, 5 months 23 days ago Mensch und Maschine Software SE Reports Strong H1 2025 Performance Financial Targets Mensch Und Maschine Profit Margins Autodesk Transition H1 2025 Results
BRIEF published on 07/23/2025 at 09:03, 5 months 23 days ago Mensch und Maschine Software SE annonce de solides performances au premier semestre 2025 Objectifs Financiers Marges Bénéficiaires L'homme Et La Machine Résultats Du Premier Semestre 2025 Transition Autodesk
BRIEF published on 07/23/2025 at 08:50, 5 months 23 days ago ODIOT SA s'engage en tant que mécène du musée des Arts décoratifs Paris Patrimoine Mécénat ODIOT SA Arts Décoratifs
BRIEF published on 07/23/2025 at 08:50, 5 months 23 days ago ODIOT SA is committed as a patron of the Museum of Decorative Arts Paris Heritage Patronage ODIOT SA Decorative Arts
BRIEF published on 07/23/2025 at 08:35, 5 months 23 days ago Experienced Biotechnology Expert Joins BRAIN Biotech Supervisory Board Biotechnology Supervisory Board Product Development Fermentation Enzymes
Published on 01/16/2026 at 00:00, 2 hours 53 minutes ago LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
Published on 01/15/2026 at 23:20, 3 hours 33 minutes ago Guanajuato Silver Closes Acquisition of Bolanitos Gold-Silver Mine
Published on 01/15/2026 at 23:15, 3 hours 38 minutes ago Drilling Resumes on The Nighthawk Gold/Silver Project, Nevada
Published on 01/15/2026 at 22:02, 4 hours 51 minutes ago Unusual Machines Announces $2.1 Million Order for Drone Components
Published on 01/15/2026 at 22:00, 4 hours 53 minutes ago Silver North Announces Brokered LIFE Private Placement for Gross Proceeds of up to C$5.0 Million
Published on 01/16/2026 at 00:30, 2 hours 23 minutes ago German Engraving Businesses Focus on Customization and Advanced Laser Technology in the New Year
Published on 01/15/2026 at 23:23, 3 hours 30 minutes ago Klöckner & Co and Worthington Steel sign business combination agreement
Published on 01/15/2026 at 23:22, 3 hours 31 minutes ago EQS-Adhoc: Klöckner & Co SE signs business combination agreement with Worthington Steel and supports voluntary public takeover offer to all shareholders
Published on 01/15/2026 at 23:20, 3 hours 33 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 01/15/2026 at 19:43, 7 hours 9 minutes ago InVivo Group and the Founders jointly announce, as part of a review of their strategic priorities, their intention to file a public buy-out offer, followed by a squeeze-out of TERACT shares
Published on 01/15/2026 at 18:06, 8 hours 46 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 4ème trimestre 2025
Published on 01/15/2026 at 17:57, 8 hours 55 minutes ago InVivo Group et les Fondateurs annoncent de concert, dans le cadre de l’évolution de leurs orientations stratégiques, leur intention de déposer une offre publique de retrait suivie d’un retrait obligatoire sur les titres TERACT
